Product
Ulipristal
Aliases
Ella, Ulipristal Acetate
Name
Ella
INN Name
ulipristal acetate
FDA Approved
Yes
3 clinical trials
3 organizations
7 indications
1 document
Indication
LeiomyomaIndication
UterineIndication
Hepatic InjuryIndication
Side EffectsIndication
EndometriosisIndication
ContraceptionIndication
Reproductive IssuesClinical trial
Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine FibroidsStatus: Terminated, Estimated PCD: 2019-12-31
Clinical trial
Phase IV Pilot Study of Ulipristal Acetate for Treatment of Endometriosis-related Pelvic PainStatus: Completed, Estimated PCD: 2016-11-01
Clinical trial
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive AutonomyStatus: Recruiting, Estimated PCD: 2023-06-01
Document
DailyMed Label: EllaOrganization
RedPharm Drug, Inc.Organization
RPK Pharmaceuticals, Inc.Organization
A-S Medication Solutions